An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention

Journal of Pharmacy and Bioallied Sciences

Volumn 7, Issue 1, 2015, Pages 9-14

  Gupta, Himanshu ^a   Aqil, M ^b   Khar, R ^b   Ali, Asgar ^b   Bhatnagar, Aseem ^c   Mittal, Gaurav ^c  

^a UNIVERSITY OF TOLEDO   (United States)

^b Faculty of Pharmacy   (United States)

^c INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Chitosan; gamma scintigraphy; in situ gel; levofloxacin; ocular tolerance; radiolabelling

Indexed keywords

ALGINIC ACID; CHITOSAN; EYE DROPS; ION; LEVOFLOXACIN; PLACEBO; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ARTICLE; BLOOD EYE BARRIER; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG INSTILLATION; DRUG RELEASE; DRUG RETENTION; DRUG TOLERABILITY; ELASTICITY; FEMALE; GAMMA SCINTIGRAPHY; GEL; GELATION; IN VITRO STUDY; MALE; NONHUMAN; PATIENT COMPLIANCE;

EID: 84922010087     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.149810     Document Type: Article

References (15)

1. Maurice DM. Kinetics of topically applied drugs. In: Saettone MS, Bucci P, Speiser P, editors. Ophthalmic Drug Delivery: Biopharmaceutical, Technological and Clinical Aspects. Vol. 11. Padova: Fidia Research Series, Liviana Press; 1987. p. 19-26.
2. Bourlais CL, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems-Recent advances. Prog Retin Eye Res 1998;17:33-58.
3. Ding S. Recent developments in ophthalmic drug delivery. Pharm Sci Technol Today 1998;1:328-35.
4. Liu Z, Li J, Nie S, Liu H, Ding P, Pan W. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm 2006;315:12-7.
5. Wang ZY, Zhang QZ, Konno M, Saito S. Sol-gel transition of alginate solution by addition of various divalent cations: 13 C-NMR spectroscopic study. Biopolymers 1993;33:703-11.
6. Honghe Z. Interaction mechanism in sol-gel transition of alginate solutions by addition of divalent cations. Carbohydr Res 1997;302:97-101.
7. Séchoy O, Tissié G, Sébastian C, Maurin F, Driot JY, Trinquand C. A new long acting ophthalmic formulation of carteolol containing alginic acid. Int J Pharm 2000;207:109-16.
8. Hervas MJ, Holgado MA, Fini A, Fell JT. In vitro evaluation of alginate beads of a diclofenac salt. Int J Pharm 1998;163:23-34.
9. Abraham S, Furtado S, Bharath S, Basavaraj BV, Deveswaran R, Madhavan V. Sustained ophthalmic delivery of ofloxacin from an ion-activated in situ gelling system. Pak J Pharm Sci 2009;22:175-9.
10. George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan-A review. J Control Release 2006;114:1-14.
11. Patel V, Patel M, Patel R. Chitosan: A unique pharmaceutical excipients. Drug Deliv Technol 2005;5:1-12.
12. Chen T, Embree HD, Brown EM, Taylor MM, Payne GF. Enzyme-catalyzed gel formation of gelatin and chitosan: Potential for in situ applications. Biomaterials 2003;24:2831-41.
13. Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G, et al. Development and characterization of 99mTc-timolol maleate for evaluating efficacy of in situ ocular drug delivery system. AAPS Pharm Sci Tech 2009;10:540-6.
14. Gupta H, Aqil M, Khar RK, Ali A, Chander P. A single reversed-phase UPLC method for quantification of levofloxacin in aqueous humour and pharmaceutical dosage forms. J Chromatogr Sci 2010;48:484-90.
15. Nagarwal RC, Kant S, Singh PN, Maiti P, Pandit JK. Polymeric nanoparticulate system: A potential approach for ocular drug delivery. J Control Release 2009;136:2-13.